Nearly 60 percent of Medicare hospice spending in 2020 was for patients with stays exceeding 180 days.
Medicare hospice spending, 2020 (in billions)
- All hospice users in 2020: $22.4
- Beneficiaries with LOS > 180 days: $13.3
- Days 1-180: $4.2
- Days 181-365: $4.1
- Days 366+: $4.9
- Beneficiaries with LOS ≤ 180 days: $9.2
Note: LOS (length of stay). “LOS” reflects the beneficiary’s lifetime LOS as of the end of 2020 (or at the time of discharge in 2020 if the beneficiary was not enrolled in hospice at the end of 2020). All spending reflected in the table occurred only in 2020. Breakout groups do not sum to totals because of rounding.
Source: MedPAC analysis of 100 percent hospice claims standard analytical file and an Acumen LLC data file on hospice lifetime length of stay (which is based on an analysis of historical claims data).
Other Articles You Might Enjoy
Message From Lisa Remington
May/June 2024 Issue
FREE CONTENT The home care industry lies at the center of chronic care management. It holds the key to reducing the overall cost of care, minimizing readmissions, emergency department visits, and offering value propositions that align with partnerships involving hospitals, health systems, ACOs, payers, and Medicare Advantage Plans.
Assessing the Effectiveness of Chronic Care Management Services
May/June 2024 Issue
SUBSCRIBER CONTENT Are you aware that both Medicare and Medicare Advantage beneficiaries are eligible for the Chronic Care Management program? It presents a remarkable opportunity to offer comprehensive care to those grappling with multiple chronic conditions. However, despite the widespread prevalence of chronic illnesses among Medicare beneficiaries, only a fraction is using the program. Which physicians are leveraging the program most frequently? What are the challenges?
Surprising Medical Conditions Dominating Home Healthcare Expenditure
May/June 2024 Issue
SUBSCRIBER CONTENT It's often assumed that heart disease ranks highest for medical condition expenditure in home healthcare. Get ready to be surprised by the real leader in medical expenditure.
